BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30)— 510(k) K221826

Substantially Equivalent

Becton, Dickinson and Company

FDA 510(k) clearance K221826 for BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30), Substantially Equivalent on 2022-12-21. Applicant: Becton, Dickinson and Company.

Clearance details

Applicant
Becton, Dickinson and Company
Product code
Code JTN
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Sparks, MD, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.